The J&J cancer drug scandal

Also: Trump administration orders NIH to eliminate $2.6 billion in federal contracts

April 4, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | Trump administration orders NIH to eliminate $2.6 billion in federal contracts The NIH is given a deadline of April 8 to make a 35% cut in services that may include specimen storage, genetic counseling, and administration. By Megan Molteni Opinion: The Johnson & Johnson cancer drug scandal that encapsulates corruption in health care EPO's history demonstrates just how unscrupulous one of America's most important companies and the nation's educated elite truly can be. By Gardiner Harris STAT+ | What FDA cuts could mean for the future of tobacco Experts say FDA cuts will create problems in tobacco regulation and enforcement, with potentially dire consequences for the fight against chronic disease. By Sarah Todd Tim Gruber for STAT STAT+ | DOJ urges judge to move forward with Medicare Advantage fraud case against UnitedHealth The government alleges UnitedHealth failed to return at least $2 billion in Medicare Advantage overpayments in a case dating back years. By Tara Bannow and Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser